PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis

References

• Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406. doi:10.3389/fcimb.2019.00406
   PubMed Web of Science ®Google Scholar
• Malireddi RKS, Kesavardhana S, Karki R, Kancharana B, Burton AR, Kanneganti TD. RIPK1 distinctly regulates Yersinia-induced inflammatory cell death, PANoptosis. Immunohorizons. 2020;4(12):789–796. doi:10.4049/immunohorizons.2000097
   PubMedGoogle Scholar
• Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y. Programmed cell death tunes tumor immunity. Front Immunol. 2022;13:847345. doi:10.3389/fimmu.2022.847345
   PubMed Web of Science ®Google Scholar
• Wang X, Sun R, Chan S, et al. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer. Front Genet. 2022;13:955355. doi:10.3389/fgene.2022.955355
   PubMedGoogle Scholar
• Samir P, Malireddi RKS, Kanneganti TD. The PANoptosome: a deadly protein complex driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:238. doi:10.3389/fcimb.2020.00238
   PubMed Web of Science ®Google Scholar
• Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022;232:108010. doi:10.1016/j.pharmthera.2021.108010
   PubMed Web of Science ®Google Scholar
• Li L, Jiang M, Qi L, et al. Pyroptosis, a new bridge to tumor immunity. Cancer Sci. 2021;112(10):3979–3994. doi:10.1111/cas.15059
   PubMed Web of Science ®Google Scholar
• Zhang CC, Li CG, Wang YF, et al. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation. Apoptosis. 2019;24(3–4):312–325. doi:10.1007/s10495-019-01515-1
   PubMed Web of Science ®Google Scholar
• Tsuchiya K. Inflammasome-associated cell death: pyroptosis, apoptosis, and physiological implications. Microbiol Immunol. 2020;64(4):252–269. doi:10.1111/1348-0421.12771
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187–192. doi:10.1038/nature13683
   PubMed Web of Science ®Google Scholar
• Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20(3):175–193. doi:10.1038/s41580-018-0089-8
   PubMed Web of Science ®Google Scholar
• Pena-Blanco A, Garcia-Saez AJ. Bax, Bak and beyond - mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416–431. doi:10.1111/febs.14186
   PubMed Web of Science ®Google Scholar
• Cavalcante GC, Schaan AP, Cabral GF, et al. A cell’s fate: an overview of the molecular biology and genetics of apoptosis. Int J Mol Sci. 2019;20(17):4133. doi:10.3390/ijms20174133
   PubMedGoogle Scholar
• Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99(4):1765–1817. doi:10.1152/physrev.00022.2018
   PubMed Web of Science ®Google Scholar
• Groenendyk J, Sreenivasaiah PK, Kim DH, Agellon LB, Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ Res. 2010;107(10):1185–1197. doi:10.1161/CIRCRESAHA.110.227033
   PubMed Web of Science ®Google Scholar
• Li B, Yi P, Zhang B, et al. Differences in endoplasmic reticulum stress signalling kinetics determine cell survival outcome through activation of MKP-1. Cell Signal. 2011;23(1):35–45. doi:10.1016/j.cellsig.2010.07.019
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu L, Naik I, Braunstein Z, Zhong J, Ren B. Transcription factor C/EBP homologous protein in health and diseases. Front Immunol. 2017;8:1612. doi:10.3389/fimmu.2017.01612
   PubMedGoogle Scholar
• Zhao J, Jitkaew S, Cai Z, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A. 2012;109(14):5322–5327. doi:10.1073/pnas.1200012109
   PubMedGoogle Scholar
• Wang Y, Kanneganti TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641–4657. doi:10.1016/j.csbj.2021.07.038
   PubMed Web of Science ®Google Scholar
• Gullett JM, Tweedell RE, Kanneganti TD. It’s all in the PAN: crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by PANoptosis underlying the totality of cell death-associated biological effects. Cells. 2022;11(9):1495. doi:10.3390/cells11091495
   PubMedGoogle Scholar
• Zhou R, Ying J, Qiu X, et al. A new cell death program regulated by toll-like receptor 9 through p38 mitogen-activated protein kinase signaling pathway in a neonatal rat model with sepsis associated encephalopathy. Chin Med J. 2022;135(12):1474–1485. doi:10.1097/CM9.0000000000002010
   PubMedGoogle Scholar
• Sarhan J, Liu BC, Muendlein HI, et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci U S A. 2018;115(46):E10888–E10897. doi:10.1073/pnas.1809548115
   PubMed Web of Science ®Google Scholar
• Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567–595. doi:10.1146/annurev-immunol-073119-095439
   PubMed Web of Science ®Google Scholar
• Husain M. Identifying caspases and their motifs that cleave proteins during Influenza A virus infection. J Vis Exp. 2022;185. doi:10.3791/64189
   Google Scholar
• Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature22393
   PubMed Web of Science ®Google Scholar
• Fritsch M, Gunther SD, Schwarzer R, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575(7784):683–687. doi:10.1038/s41586-019-1770-6
   PubMed Web of Science ®Google Scholar
• Jiang M, Qi L, Li L, Wu Y, Song D, Li Y. Caspase-8: a key protein of cross-talk signal way in “PANoptosis” in cancer. Int J Cancer. 2021;149(7):1408–1420. doi:10.1002/ijc.33698
   PubMedGoogle Scholar
• Taabazuing CY, Okondo MC, Bachovchin DA. Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem Biol. 2017;24(4):507–514 e504. doi:10.1016/j.chembiol.2017.03.009
   PubMed Web of Science ®Google Scholar
• Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10(1):1689. doi:10.1038/s41467-019-09397-2
   PubMed Web of Science ®Google Scholar
• Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325(5938):332–336. doi:10.1126/science.1172308
   PubMed Web of Science ®Google Scholar
• Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99–114. doi:10.1038/s41418-018-0212-6
   PubMed Web of Science ®Google Scholar
• Rathkey JK, Zhao J, Liu Z, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018;3(26). doi:10.1126/sciimmunol.aat2738
   PubMed Web of Science ®Google Scholar
• Sundaram B, Karki R, Kanneganti TD. NLRC4 deficiency leads to enhanced phosphorylation of MLKL and necroptosis. Immunohorizons. 2022;6(3):243–252. doi:10.4049/immunohorizons.2100118
   PubMedGoogle Scholar
• Hao Y, Yang B, Yang J, et al. ZBP1: a powerful innate immune sensor and double-edged sword in host immunity. Int J Mol Sci. 2022;23(18):10224. doi:10.3390/ijms231810224
   PubMedGoogle Scholar
• Kesavardhana S, Malireddi RKS, Burton AR, et al. The Zalpha2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development. J Biol Chem. 2020;295(24):8325–8330. doi:10.1074/jbc.RA120.013752
   PubMedGoogle Scholar
• Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297(1):26–38. doi:10.1111/imr.12909
   PubMed Web of Science ®Google Scholar
• Banoth B, Tuladhar S, Karki R, et al. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem. 2020;295(52):18276–18283. doi:10.1074/jbc.RA120.015924
   PubMedGoogle Scholar
• Karki R, Sundaram B, Sharma BR, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021;37(3):109858. doi:10.1016/j.celrep.2021.109858
   PubMedGoogle Scholar
• Zheng M, Karki R, Vogel P, Kanneganti TD. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell. 2020;181(3):674–687 e613. doi:10.1016/j.cell.2020.03.040
   PubMed Web of Science ®Google Scholar
• Zheng M, Kanneganti TD. Newly identified function of Caspase-6 in ZBP1-mediated innate immune responses, NLRP3 Inflammasome Activation, PANoptosis, and host defense. J Cell Immunol. 2020;2(6):341–347. doi:10.33696/immunology.2.064
   PubMedGoogle Scholar
• Karki R, Lee S, Mall R, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol. 2022;7(74):eabo6294. doi:10.1126/sciimmunol.abo6294
   PubMedGoogle Scholar
• Tao P, Sun J, Wu Z, et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature. 2020;577(7788):109–114. doi:10.1038/s41586-019-1830-y
   PubMed Web of Science ®Google Scholar
• Lalaoui N, Boyden SE, Oda H, et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature. 2020;577(7788):103–108. doi:10.1038/s41586-019-1828-5
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature. 2011;471(7338):373–376. doi:10.1038/nature09878
   PubMedGoogle Scholar
• Dillon CP, Weinlich R, Rodriguez DA, et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell. 2014;157(5):1189–1202. doi:10.1016/j.cell.2014.04.018
   PubMed Web of Science ®Google Scholar
• Samir P, Kanneganti TD. DDX3X sits at the crossroads of liquid-liquid and prionoid phase transitions arbitrating life and death cell fate decisions in stressed cells. DNA Cell Biol. 2020;39(7):1091–1095. doi:10.1089/dna.2020.5616
   PubMedGoogle Scholar
• Malireddi RKS, Gurung P, Kesavardhana S, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020;217(3). doi:10.1084/jem.20191644
   PubMed Web of Science ®Google Scholar
• Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149–168 e117. doi:10.1016/j.cell.2020.11.025
   PubMed Web of Science ®Google Scholar
• Sundaram B, Kanneganti TD. Advances in understanding activation and function of the NLRC4 Inflammasome. Int J Mol Sci. 2021;22(3):1048. doi:10.3390/ijms22031048
   PubMed Web of Science ®Google Scholar
• Zheng M, Williams EP, Malireddi RKS, et al. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection. J Biol Chem. 2020;295(41):14040–14052. doi:10.1074/jbc.RA120.015036
   PubMed Web of Science ®Google Scholar
• Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597(7876):415–419. doi:10.1038/s41586-021-03875-8
   PubMedGoogle Scholar
• Place DE, Lee S, Kanneganti TD. PANoptosis in microbial infection. Curr Opin Microbiol. 2021;59:42–49. doi:10.1016/j.mib.2020.07.012
   PubMed Web of Science ®Google Scholar
• Jiang W, Deng Z, Dai X, Zhao W. PANoptosis: a new insight into oral infectious diseases. Front Immunol. 2021;12:789610. doi:10.3389/fimmu.2021.789610
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang W, Yi W, et al. Pathway of cell death and its role in virus infection. Viral Immunol. 2022;35(7):444–456. doi:10.1089/vim.2022.0010
   Google Scholar
• Nisa A, Kipper FC, Panigrahy D, Tiwari S, Kupz A, Subbian S. Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection. Am J Physiol Cell Physiol. 2022;323(5):C1444–C1474. doi:10.1152/ajpcell.00246.2022
   PubMedGoogle Scholar
• Place DE, Christgen S, Tuladhar S, Vogel P, Malireddi RKS, Kanneganti TD. Hierarchical cell death program disrupts the intracellular niche required for Burkholderia thailandensis pathogenesis. mBio. 2021;12(3):e0105921. doi:10.1128/mBio.01059-21
   PubMedGoogle Scholar
• Chi D, Lin X, Meng Q, Tan J, Gong Q, Tong Z. Real-time induction of macrophage apoptosis, pyroptosis, and necroptosis by Enterococcus faecalis OG1RF and two root canal isolated strains. Front Cell Infect Microbiol. 2021;11:720147. doi:10.3389/fcimb.2021.720147
   PubMed Web of Science ®Google Scholar
• Nguyen LN, Kanneganti TD. PANoptosis in viral infection: the missing puzzle piece in the cell death field. J Mol Biol. 2022;434(4):167249. doi:10.1016/j.jmb.2021.167249
   PubMedGoogle Scholar
• Kuriakose T, Kanneganti TD. Pyroptosis in Antiviral Immunity. Curr Top Microbiol Immunol. 2019. doi:10.1007/82_2019_189
   PubMedGoogle Scholar
• Lee S, Channappanavar R, Kanneganti TD. Coronaviruses: innate immunity, inflammasome activation, inflammatory cell death, and cytokines. Trends Immunol. 2020;41(12):1083–1099. doi:10.1016/j.it.2020.10.005
   PubMed Web of Science ®Google Scholar
• Yapasert R, Khaw-On P, Banjerdpongchai R. Coronavirus infection-associated cell death signaling and potential therapeutic targets. Molecules. 2021;26:24. doi:10.3390/molecules26247459
   Google Scholar
• Schifanella L, Anderson J, Wieking G, et al. The defenders of the alveolus succumb in COVID-19 pneumonia to SARS-CoV-2, necroptosis, pyroptosis and panoptosis. bioRxiv. 2022. doi:10.1101/2022.08.06.503050
   PubMedGoogle Scholar
• Briard B, Malireddi RKS, Kanneganti TD, Chowdhary A. Role of inflammasomes/pyroptosis and PANoptosis during fungal infection. PLoS Pathog. 2021;17(3):e1009358. doi:10.1371/journal.ppat.1009358
   PubMedGoogle Scholar
• Pan B, Zheng B, Xing C, Liu J. Non-canonical programmed cell death in colon cancer. Cancers. 2022;14(14):3309. doi:10.3390/cancers14143309
   PubMedGoogle Scholar
• Gong L, Huang D, Shi Y, Liang Z, Bu H. Regulated cell death in cancer: from pathogenesis to treatment. Chin Med. 2022. doi:10.1097/CM9.0000000000002239
   Google Scholar
• Sharma BR, Kanneganti TD. Inflammasome signaling in colorectal cancer. Transl Res. 2022. doi:10.1016/j.trsl.2022.09.002
   Google Scholar
• Huang J, Jiang S, Liang L, et al. Analysis of PANoptosis-related LncRNA-miRNA-mRNA network reveals LncRNA SNHG7 involved in chemo-resistance in colon adenocarcinoma. Front Oncol. 2022;12:888105. doi:10.3389/fonc.2022.888105
   PubMedGoogle Scholar
• Karki R, Sharma BR, Lee E, et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020;5(12). doi:10.1172/jci.insight.136720
   PubMedGoogle Scholar
• Lin JF, Hu PS, Wang YY, et al. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduct Target Ther. 2022;7(1):54. doi:10.1038/s41392-022-00889-0
   PubMedGoogle Scholar
• Malireddi RKS, Karki R, Sundaram B, et al. Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth. Immunohorizons. 2021;5(7):568–580. doi:10.4049/immunohorizons.2100059
   PubMedGoogle Scholar
• Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin Immunol. 2022;238:109019. doi:10.1016/j.clim.2022.109019
   PubMed Web of Science ®Google Scholar
• Ren L, Yang Y, Li W, et al. CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2/M phase transition, and PANoptosis. J Transl Med. 2022;20(1):444. doi:10.1186/s12967-022-03641-y
   PubMed Web of Science ®Google Scholar
• Song M, Xia W, Tao Z, et al. Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy. Drug Deliv. 2021;28(1):594–606. doi:10.1080/10717544.2021.1898703
   PubMed Web of Science ®Google Scholar
• Messaoud-Nacer Y, Culerier E, Rose S, et al. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). Cell Death Dis. 2022;13(3):269. doi:10.1038/s41419-022-04664-5
   PubMedGoogle Scholar
• Cui Y, Wang X, Lin F, et al. MiR-29a-3p improves acute lung injury by reducing alveolar epithelial cell PANoptosis. Aging Dis. 2022;13(3):899–909. doi:10.14336/AD.2021.1023
   PubMed Web of Science ®Google Scholar
• Shu J, Yang L, Wei W, Zhang L. Identification of programmed cell death-related gene signature and associated regulatory axis in cerebral ischemia/reperfusion injury. Front Genet. 2022;13:934154. doi:10.3389/fgene.2022.934154
   PubMedGoogle Scholar
• Yan WT, Yang YD, Hu XM, et al. Do pyroptosis, apoptosis, and necroptosis (PANoptosis) exist in cerebral ischemia? Evidence from cell and rodent studies. Neural Regen Res. 2022;17(8):1761–1768. doi:10.4103/1673-5374.331539
   PubMedGoogle Scholar
• Gonzalez-Rodriguez P, Fernandez-Lopez A. PANoptosis: new insights in regulated cell death in ischemia/reperfusion models. Neural Regen Res. 2023;18(2):342–343. doi:10.4103/1673-5374.343910
   PubMedGoogle Scholar
• Uysal E, Dokur M, Kucukdurmaz F, et al. Targeting the PANoptosome with 3,4-Methylenedioxy-beta-Nitrostyrene, reduces PANoptosis and protects the kidney against renal ischemia-reperfusion injury. J Invest Surg. 2022:1–12. doi:10.1080/08941939.2022.2128117
   Google Scholar
• Yan WT, Zhao WJ, Hu XM, et al. PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons. Neural Regen Res. 2023;18(2):357–363. doi:10.4103/1673-5374.346545
   PubMed Web of Science ®Google Scholar
• Ye D, Xu Y, Shi Y, et al. Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model. J Pineal Res. 2022;73(4):e12828. doi:10.1111/jpi.12828
   PubMedGoogle Scholar
• Xu X, Lan X, Fu S, et al. Dickkopf-1 exerts protective effects by inhibiting PANoptosis and retinal neovascularization in diabetic retinopathy. Biochem Biophys Res Commun. 2022;617(Pt 2):69–76. doi:10.1016/j.bbrc.2022.05.001
   PubMedGoogle Scholar